CV Sciences (CVSI) Cash & Equivalents (2010 - 2026)
CV Sciences (CVSI) posted Cash & Equivalents of $309000.0 for Q1 2026, up 11.15% sequentially from $278000.0 in Q4 2025, and down 61.95% YoY from $812000.0 in Q1 2025.
CV Sciences (CVSI) Cash & Equivalents (2010 - 2026) Analysis & Trends
CV Sciences has reported Cash & Equivalents for 17 years, with the latest figure at $309000.0 in Q1 2026.
- Quarterly Cash & Equivalents fell 61.95% year-over-year to $309000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $309000.0 (down 61.95% YoY) and the FY2025 annual result came in at $278000.0, down 38.77% from the prior year.
- Cash & Equivalents improved to $309000.0 in Q1 2026 per CVSI's latest filing, from $278000.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $2.4 million in Q1 2022 and troughed at $278000.0 in Q4 2025.
- A 5-year average of $935588.2 and a median of $812000.0 in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 115.55% in 2023, then sank 71.78% in 2024.
- Over 5 years, Cash & Equivalents stood at $611000.0 in 2022, then soared by 115.55% to $1.3 million in 2023, then plunged by 65.53% to $454000.0 in 2024, then sank by 38.77% to $278000.0 in 2025, then gained by 11.15% to $309000.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $309000.0, $278000.0, and $381000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 266,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 266,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 886,000.00 |
| Mar 31, 2025 | 812,000.00 |
| Dec 31, 2024 | 454,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 477,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 714,000.00 |
| Dec 31, 2022 | 611,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 2.44 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Jun 30, 2021 | 2.46 Mn |